SB 59 — AN ACT relating to drug paraphernalia.
Last action — to Health Services (S)
-
✓Introduced
-
2In Committee
-
3Passed Senate
-
4Passed House
-
5To Executive
-
6Enacted
This bill died with 2023 Regular Session. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
This bill is no longer active — its legislative session has ended, so there is no live prognosis. It would have to be reintroduced in the current session to move again.
Summary
Amend KRS 218A.500 to exclude testing equipment, including drug testing strips, used to determine the presence of fentanyl or a fentanyl-derivative from the definition of drug paraphernalia; allow local health departments to provide testing equipment, including drug testing strips, to determine the presence of fentanyl or a fentanyl derivative to participants; allow the retail sale of testing equipment, including drug testing strips, used to determine the presence of fentanyl or a fentanyl derivative; exclude testing equipment, including drug testing strips, used to determine the presence of fentanyl or a fentanyl-derivative in the inventory of a pharmacy from classification of drug paraphernalia.
Bill Text
- Introduced View text Current pdf
Action History
-
to Health Services (S)
-
to Committee on Committees (S)
-
introduced in Senate
Sponsorship breakdown
Export CSV (upgrade) →0 sponsors · 0 co-sponsors · 138 not signed on
Sponsors (0)
None.
Co-sponsors (0)
None.
Not signed on (138)
138 members have not signed on to this bill.
Show all 138 →"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.
Subjects
Frequently asked questions
- What does SB 59 do?
- Amend KRS 218A.500 to exclude testing equipment, including drug testing strips, used to determine the presence of fentanyl or a fentanyl-derivative from the definition of drug paraphernalia; allow local health departments to provide testing equipment, including drug testing strips, to determine the presence of fentanyl or a fentanyl derivative to participants; allow the retail sale of testing equipment, including drug testing strips, used to determine the presence of fentanyl or a fentanyl derivative; exclude testing equipment, including drug testing strips, used to determine the presence of fentanyl or a fentanyl-derivative in the inventory of a pharmacy from classification of drug paraphernalia.
- What is the current status of SB 59?
- This bill died with 2023 Regular Session. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
- Where can I track SB 59?
- Track SB 59 free on One Click Politics — get push/email alerts when it moves.
Make your voice heard on SB 59
Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.
Stay ahead of SB 59
Last checked for changes 2 months ago · updated continuously
One Click Politics tracks every bill in Congress and all 50 states.
Track this bill →